US$ 29.10
glp 1 small molecule Synthetic GLP-1 secretagogues prepared by means of a three-component indole annulation strategy How GLP-1 Receptor Agonists Evolved
Description
Independent Association between Prediabetes and Future Pancreatic Fat Accumulation: a 5-year Japanese Cohort Study

doi: 10.2337/dc13-2760
Coadministration of JANUVIA with an insulin secretagogue (e.g., sulfonylurea) or insulin may require lower doses of the insulin secretagogue or insulin to reduce the risk of hypoglycemia

GLP-1 medications are meant to be long-term treatments for diabetes or obesity

A more helpful approach is to track other markers that tell a fuller story

Patients considering GLP-1 therapy should always consult with their physician to discuss potential risks and benefits
